INSPIRE MEDICAL SYSTEM ($INSP) posted quarterly earnings results on Monday, August 4th. The company reported earnings of $0.45 per share, beating estimates of $0.21 by $0.24. The company also reported revenue of $217,090,000, missing estimates of $218,591,355 by $-1,501,355.
You can see Quiver Quantitative's $INSP stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
INSPIRE MEDICAL SYSTEM Insider Trading Activity
INSPIRE MEDICAL SYSTEM insiders have traded $INSP stock on the open market 17 times in the past 6 months. Of those trades, 0 have been purchases and 17 have been sales.
Here’s a breakdown of recent trading of $INSP stock by insiders over the last 6 months:
- RANDY BAN (See Remarks) has made 0 purchases and 13 sales selling 29,531 shares for an estimated $5,428,261.
- JOHN RONDONI (See Remarks) has made 0 purchases and 3 sales selling 4,604 shares for an estimated $782,887.
- SHAWN MCCORMICK sold 360 shares for an estimated $57,600
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
INSPIRE MEDICAL SYSTEM Hedge Fund Activity
We have seen 196 institutional investors add shares of INSPIRE MEDICAL SYSTEM stock to their portfolio, and 172 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 759,090 shares (+214.5%) to their portfolio in Q1 2025, for an estimated $120,907,855
- DRAGONEER INVESTMENT GROUP, LLC added 426,493 shares (+49.0%) to their portfolio in Q1 2025, for an estimated $67,931,805
- ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC removed 267,124 shares (-87.1%) from their portfolio in Q2 2025, for an estimated $34,664,681
- MARSHALL WACE, LLP removed 261,803 shares (-94.5%) from their portfolio in Q1 2025, for an estimated $41,699,981
- FULLER & THALER ASSET MANAGEMENT, INC. removed 232,388 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $37,014,760
- WASATCH ADVISORS LP added 202,342 shares (+15.3%) to their portfolio in Q1 2025, for an estimated $32,229,033
- BANK OF NEW YORK MELLON CORP removed 200,611 shares (-34.5%) from their portfolio in Q1 2025, for an estimated $31,953,320
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
INSPIRE MEDICAL SYSTEM Government Contracts
We have seen $3,895,079 of award payments to $INSP over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- BILL PAY TRANSACTIONS FOR SURGICAL IMPLANTS.: $116,381
- VISN 12 PROSTHETICS PURCHASES FY24 WITH INSPIRE MED SYSTEMS INC: $75,226
- PROSTHETIC ORDER - IMPLANT ITEMS: $75,226
- IMPLANT: $50,150
- IMPLANTABLE PULSE GENERATOR: $50,150
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
INSPIRE MEDICAL SYSTEM Analyst Ratings
Wall Street analysts have issued reports on $INSP in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Morgan Stanley issued a "Overweight" rating on 07/15/2025
- JP Morgan issued a "Overweight" rating on 05/06/2025
- Baird issued a "Outperform" rating on 05/06/2025
- Keybanc issued a "Overweight" rating on 04/21/2025
- RBC Capital issued a "Outperform" rating on 04/15/2025
- Truist Securities issued a "Buy" rating on 02/11/2025
- Piper Sandler issued a "Overweight" rating on 02/10/2025
To track analyst ratings and price targets for INSPIRE MEDICAL SYSTEM, check out Quiver Quantitative's $INSP forecast page.
INSPIRE MEDICAL SYSTEM Price Targets
Multiple analysts have issued price targets for $INSP recently. We have seen 10 analysts offer price targets for $INSP in the last 6 months, with a median target of $206.0.
Here are some recent targets:
- Brett Fishbin from Keybanc set a target price of $197.0 on 07/22/2025
- Kallum Titchmarsh from Morgan Stanley set a target price of $182.0 on 07/15/2025
- Robbie Marcus from JP Morgan set a target price of $195.0 on 05/06/2025
- Larry Biegelsen from Wells Fargo set a target price of $174.0 on 05/06/2025
- Mike Polark from Baird set a target price of $236.0 on 05/06/2025
- Jonathan Block from Stifel set a target price of $175.0 on 04/21/2025
- Shagun Singh from RBC Capital set a target price of $215.0 on 04/15/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
